Filing Details
- Accession Number:
- 0001237899-13-000053
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-09-20 16:33:46
- Reporting Period:
- 2013-09-18
- Filing Date:
- 2013-09-20
- Accepted Time:
- 2013-09-20 16:33:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 872589 | Regeneron Pharmaceuticals Inc | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1013064 | Roy P Vagelos | 777 Old Saw Mill River Road Tarrytown NY 10591 | Chairman Of The Board | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-09-18 | 312,500 | $13.00 | 378,259 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-09-18 | 13,346 | $304.38 | 364,913 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2013-09-18 | 153,798 | $304.38 | 211,115 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2013-09-19 | 61,159 | $300.34 | 149,956 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-09-19 | 21,179 | $301.42 | 128,777 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-09-19 | 10,742 | $302.86 | 118,035 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-09-19 | 6,780 | $303.49 | 111,255 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-09-19 | 11,286 | $304.80 | 99,969 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-09-19 | 13,126 | $305.28 | 86,843 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-09-19 | 5,084 | $306.46 | 81,759 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-09-19 | 4,500 | $308.40 | 77,259 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-09-19 | 2,600 | $309.84 | 74,659 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-09-19 | 8,900 | $310.18 | 65,759 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-07-05 | 921 | $0.00 | 159,267 | No | 5 | G | Indirect | by CLAT |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 5 | G | Indirect | by CLAT |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2013-09-18 | 312,500 | $0.00 | 312,500 | $13.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2013-12-15 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 73,597 | Indirect | by GRAT |
| Common Stock | 2,352 | Indirect | By 401(k) Plan |
| Common Stock | 15,162 | Indirect | by GRAT |
| Common Stock | 3 | Indirect | by GRAT |
| Common Stock | 114,750 | Indirect | by Spouse as Trustee |
| Common Stock | 1,203 | Indirect | by trust for grandch |
Footnotes
- Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- Represents volume-weighted average price of sales of 61,159 shares of Company stock on September 19, 2013 at prices ranging from $300.00 to $300.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 19, 2013 at each separate price.
- Represents volume-weighted average price of sales of 21,179 shares of Company stock on September 19, 2013 at prices ranging from $301.00 to $301.74. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 19, 2013 at each separate price.
- Represents volume-weighted average price of sales of 10,742 shares of Company stock on September 19, 2013 at prices ranging from $302.56 to $302.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 19, 2013 at each separate price.
- Represents volume-weighted average price of sales of 6,780 shares of Company stock on September 19, 2013 at prices ranging from $303.07 to $303.83. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 19, 2013 at each separate price.
- Represents volume-weighted average price of sales of 11,286 shares of Company stock on September 19, 2013 at prices ranging from $304.19 to $304.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 19, 2013 at each separate price.
- Represents volume-weighted average price of sales of 13,126 shares of Company stock on September 19, 2013 at prices ranging from $305.00 to $300.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 19, 2013 at each separate price.
- Represents volume-weighted average price of sales of 5,084 shares of Company stock on September 19, 2013 at prices ranging from $306.10 to $306.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 19, 2013 at each separate price.
- Represents volume-weighted average price of sales of 4,500 shares of Company stock on September 19, 2013 at prices ranging from $308.05 to $308.70. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 19, 2013 at each separate price.
- Represents volume-weighted average price of sales of 2,600 shares of Company stock on September 19, 2013 at prices ranging from $309.09 to $309.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 19, 2013 at each separate price.
- Represents volume-weighted average price of sales of 8,900 shares of Company stock on September 19, 2013 at prices ranging from $310.00 to $310.51. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 19, 2013 at each separate price.
- By a trust for the benefit of certain grandchildren of the reporting person, of which the reporting person and/or the spouse of the reporting person is trustee.
- The stock option becomes 100% exercisable one year after the date of grant.
Billionaire Hedge Funds
